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Aging, Tufts University and Tufts University School of Medicine, Boston, Massachusetts 02111;
Diagnostic Division (K.N., T.N.), Otsuka Pharmaceutical Co., Ltd., Tokyo 101-8535, Japan; and Denka
Seiken Co., Ltd. (Y.I.), Tokyo103-0025, Japan
Context: The American Heart Association Nutrition Committee recommends women and men con-
sumenomore than 100 and 150 kcal of added sugar per day, respectively,whereas theDietaryGuide-
lines for Americans, 2010, suggests a maximal added sugar intake of 25% or less of total energy.
Objective: To address this discrepancy, we compared the effects of consuming glucose, fructose,
or high-fructose corn syrup (HFCS) at 25% of energy requirements (E) on risk factors for cardio-
vascular disease.
Participants, Design and Setting, and Intervention: Forty-eight adults (aged 18–40 yr; body mass
index 18–35 kg/m2) resided at the Clinical Research Center for 3.5 d of baseline testing while
consumingenergy-balanceddiets containing55%Ecomplex carbohydrate. For12outpatientdays,
they consumed usual ad libitum diets along with three servings per day of glucose, fructose, or
HFCS-sweetened beverages (n  16/group), which provided 25% E requirements. Subjects then
consumed energy-balanced diets containing 25% E sugar-sweetened beverages/30% E complex
carbohydrate during 3.5 d of inpatient intervention testing.
Main Outcome Measures: Twenty-four-hour triglyceride area under the curve, fasting plasma
low-density lipoprotein (LDL), and apolipoprotein B (apoB) concentrations were measured.
Results:Twenty-four-hour triglycerideareaunder the curvewas increased comparedwithbaseline
during consumption of fructose (4.7  1.2 mmol/liter  24 h, P  0.0032) and HFCS (1.8  1.4
mmol/liter 24 h, P 0.035) but not glucose (1.9 0.9 mmol/liter 24 h, P 0.14). Fasting LDL
and apoB concentrations were increased during consumption of fructose (LDL: 0.29  0.082
mmol/liter, P  0.0023; apoB: 0.093  0.022 g/liter, P  0.0005) and HFCS (LDL: 0.42  0.11
mmol/liter, P  0.0001; apoB: 0.12  0.031 g/liter, P  0.0001) but not glucose (LDL: 0.012 
0.071 mmol/liter, P  0.86; apoB: 0.0097  0.019 g/liter, P  0.90).
Conclusions: Consumption of HFCS-sweetened beverages for 2 wk at 25% E increased risk factors
for cardiovascular disease comparablywith fructose andmore than glucose in young adults. (J Clin
Endocrinol Metab 96: E1596–E1605, 2011)
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Abbreviations: apo, Apolipoprotein; AUC, area under the curve; BMI, body mass index;
BW, change in bodyweight; C, cholesterol; CCRC, University of California, Davis, Clinical
Research Center; E, energy requirements; HDL, high-density lipoprotein; HFCS, high-fruc-
tose corn syrup; HOMA-IR, homeostasis model assessment insulin resistance index; LDL,
low-density lipoprotein; LS means, least squares means; RLP, remnant lipoprotein;
sdLDL-C, small dense LDL-C; TG, triglyceride.
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In epidemiological studies, consumption of sugar and/orsugar-sweetened beverages has been linked to the pres-
ence of unfavorable lipid levels (1–5), insulin resistance (6,
7), fatty liver (8, 9), type 2 diabetes (10–12), cardiovas-
cular disease (13), andmetabolic syndrome (14).We have
recently reported that consumption of fructose-sweetened
beverages at 25% of energy requirements (E) increased
visceral adipose deposition and de novo lipogenesis, pro-
duced dyslipidemia, and decreased glucose tolerance/in-
sulin sensitivity in older, overweight/obese men and
women, whereas consumption of glucose-sweetened bev-
erages did not (15). Because the commonly consumed sug-
ars, sucrose and high-fructose corn syrup (HFCS), are
composed of 50–55% fructose, these results provide a
potential mechanistic explanation for the associations be-
tween sugar consumption and metabolic disease. How-
ever, the adverse metabolic effects of fructose consump-
tion observed in the older, overweight/obese population
(15) may not occur in a younger, leaner population.
Authors of three recent reviews have concluded that
long-term sugar intakes as high as 25–50% E have no
adverse effects with respect to components of metabolic
syndrome (16) and that fructose consumption up to 140
g/d does not result in biologically relevant increases of
fasting or postprandial triglycerides (TG) in healthy, nor-
mal-weight (17), or overweight or obese (18) humans.
These reviews (16, 17) are cited in the Report of the Di-
etary Guidelines Advisory Committee on the Dietary
Guidelines for Americans 2010, released June of 2010, in
whichamaximal intake level of 25%or less of total energy
from added sugars is suggested (19). However, in August
of 2009, the AmericanHeart AssociationNutrition Com-
mittee recommended that women consume no more than
100 kcal/d and men consume no more than 150 kcal/d of
added sugar (20). This equates to differences between the
two guidelines of 400 kcal/d for women consuming 2000
kcal/d and 525 kcal/d formen consuming 2500 kcal/d. To
address this discrepancy, we compared the effects of con-
suming25%Eas glucose, fructose orHFCS for 2weeks on
risk factors for cardiovascular disease in young adults.
Materials and Methods
The subjects who participated in this study are a subgroup of
participants from an ongoing 5-yrNational Institutes of Health-
funded investigation in which a total of eight experimental
groups (n  25/group) will be studied. The objectives include
comparing the metabolic effects of fructose, glucose, and HFCS
consumption at 25% E and to compare the metabolic effects of
fructose andHFCS consumption at 0, 10, 17.5, and 25%E. The
results reported in this paper are from the first 48 subjects to
complete the study protocol in the experimental groups consum-
ing 25% E as glucose, fructose, or HFCS (n  16/group). Par-
ticipants were recruited through an internet listing (Craigslist-
.com) and underwent telephone and in-person interviews with
medical history, complete blood count, and serum biochemistry
panel to assess eligibility. Inclusion criteria included age 18–40
yr and bodymass index (BMI) 18–35 kg/m2with a self-report of
stable body weight during the prior 6months. Exclusion criteria
includeddiabetes (fasting glucose125mg/dl), evidenceof renal
or hepatic disease, fasting plasma TG greater than 400 mg/dl,
hypertension (140/90 mm Hg), or surgery for weight loss. In-
dividuals who smoked, habitually ingested more than two alco-
holic beverages per day, exercised more than 3.5 h/wk at a level
more vigorous than walking, or used thyroid, lipid-lowering,
glucose-lowering, antihypertensive, antidepressant, or weight
loss medications were also excluded. The University of Califor-
nia, Davis, Institutional Review Board approved the experimen-
tal protocol for this study, and subjects provided written in-
formed consent to participate.
For the 5 wk before study, subjects were asked to limit daily
consumption of sugar-containing beverages to one 8-oz serving
of fruit juice. Fifty-five subjectswere enrolled in the experimental
groups consuming 25% E as glucose, fructose, or HFCS. Four
subjectswithdrewdue to unwillingness to complywith the study
protocol (two in theHFCSgroup, twobefore groupassignment),
and twowerewithdrawndue tomedical conditions not apparent
during screening (HFCS and glucose group). The samples from
one subject (HFCS group) who completed the study protocol
were not analyzed because of illness during the 24-h serial blood
collection. The experimental groups were matched for gender
(nine men, seven women/group), BMI, fasting TG, cholesterol,
high-density lipoprotein (HDL) and insulin concentrations. The
subjects and University of California, Davis, Clinical Research
Center (CCRC) and technical personnel were blinded to the
sugar assignments.
This was a parallel-arm, diet intervention study with three
phases: 1) a3.5-d inpatient baselineperiodduringwhich subjects
resided at the CCRC; 2) a 12-d outpatient intervention period;
and3) a3.5-d inpatient interventionperiodat theCCRC.During
d 2 and 3 of the baseline and intervention inpatient periods,
subjects consumed energy-balanced meals consisting of conven-
tional foods. Daily energy requirements were calculated by the
Mifflin equation (21) with adjustment of 1.3 for activity on the
days of the 24-h serial blood collections, and adjustment of 1.5
for the other days. The baseline diet contained 55% Emainly as
complex carbohydrate, 30% fat, and 15% protein. The inter-
vention inpatient meals were as identical as possible to baseline
meals, excepting the carbohydrate component consisted of 25%
E as glucose-, fructose-, or HFCS-sweetened beverages and 30%
E as complex carbohydrate. Sugar-sweetened beverages were
provided to subjects as three daily servings consumedwithmeals
and were flavored with an unsweetened drink mix (Kool-Aid;
Kraft Foods,Northfield, IL).The timingof inpatientmeal service
and the energy distribution were: breakfast, 0900 h (25%);
lunch, 1300 h (35%); dinner, 1800 h (40%).
During the 12-d outpatient phase of the study, the subjects
were provided with and instructed to drink three servings of
sugar-sweetened beverage per day (one per meal), to consume
their usual diet, and to not consume other sugar-containing bev-
erages, including fruit juice. To monitor compliance, the sugar-
sweetened beverages contained a biomarker (riboflavin), which
was measured fluorometrically in urine samples collected at the
time of beverage pickup. These measurements indicated that the
three groups of subjects were comparably compliant.
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Twenty-four-hour serial blood collectionswere conductedon
the third day of the baseline (0 wk) and intervention (2 wk)
inpatient periods. Three fasting blood samples were collected at
0800, 0830, and 0900 h. Twenty-nine postprandial blood sam-
ples were collected at 30- to 60-min intervals from 0930 until
0800 h the next morning. Additional 6-ml samples were col-
lected at the fasting timepoints, 0800, 0830, and0900hand also
at 2200, 2300, and 2400 h, the period during which TG con-
centrations peaked during our previous study (15). The addi-
tional plasma from the three fasting samples was pooled, as was
that from the three late-evening postprandial samples; multiple
aliquots of each pooled sample were stored at 80 C.
Analyses
Primary outcomes include fasting TG, 24-h TG incremental
area under the curve (AUC), late-evening postprandial TG con-
centrations, and fasting LDL, non-HDL-cholesterol (-C), apoli-
poprotein (apo)B concentrations, and the apoB to apoAI ratio.
Secondary outcomes included body weight, fasting HDL, post-
prandial LDL, non-HDL-C, apoB, remnant lipoprotein-choles-
terol (RLP)-C and RLP-TG, and fasting and postprandial small
dense LDL-cholesterol (sdLDL-C). Fasting concentrations, 24-h
AUC, andpostmeal peaks for glucose and insulin, andhomeostasis
model assessment insulin resistance index (HOMA-IR) are pre-
sented in the online supplement, published on The Endocrine So-
ciety’s Journals Online web site at http://jcem.endojournals.org.
Fasting measures were conducted on samples collected or pooled
from the 0800, 0830, and 0900 h time points, and postprandial
measures were conducted on samples collected or pooled from
the 2200, 2300, and 2400 h time points. Lipid and lipoprotein
concentrations (total cholesterol, HDL, TG, apoB, apoA1) were
determined with a Polychem chemistry analyzer (PolyMedCo,
Inc., Cortlandt Manor, NY). LDL concentrations were deter-
mined by direct homogenous assay using detergents (Denka
Seiken, Tokyo, Japan) (22) and sdLDL-C concentrations were
quantified using the sdLDL-C-EX“SEIKEN” homogeneous as-
say kit (Denka Seiken) (23). RLP concentrationswere quantified
with an immunoseparation assay (24). Glucose was measured
with an automated glucose analyzer (YSI, Inc., Yellow Springs,
OH), and insulin by RIA (Millipore, St. Charles, MO).
The incremental 24-h area AUC was calculated for TG, glu-
cose, and insulin by the trapezoidal method. Glucose and insulin
postmeal peakswere assessedas themeanamplitudesof the three
postmeal peaks; specifically the peak postmeal value minus the
premeal value was averaged for breakfast, lunch, and dinner for
each subject. The absolute change ( from 2 wk when 25% E
sugar/30% E complex carbohydrate was consumed compared
with 0 wk when 55% E complex carbohydrate was consumed)
for each outcomewas analyzed with SAS 9.2 (SAS, Cary, NC) in
amixed procedures (PROCMIXED)model with sugar and gen-
der as factors, and BMI, the change (2 to 0 wk) in body weight
(BW), and outcome concentration at baseline (outcomeB) as
continuous covariables. BW and outcomeB were removed if
they did not improve the precision of the model. Significant dif-
ferences (P 0.05) among the three sugarswere identified by the
Tukey’s multiple comparisons test. Outcomes that were signif-
icantly affected by 2wk of glucose, fructose, or HFCS consump-
tion were identified as least squares means (LS means) of the
change significantly different than zero. Primary outcomes were
also analyzed with BMI as a factor (BMI 25 m/kg2 vs. 25
m/kg2). Data are presented as mean  SEM.
Results
There were no significant differences among the three ex-
perimental groups in anthropomorphic (Table 1) or out-
come measures at baseline (Tables 2 and 3 and Supple-
mentalTable1). Bodyweight (Table3) andbloodpressure
(data not shown) were not affected by 2 wk consumption
of glucose, fructose, or HFCS.
Primary outcomes: comparing glucose,
fructose, and HFCS with complex
carbohydrate consumption
Table 2 presents the primary outcomes during consump-
tion of complex carbohydrate at baseline (0 wk) and at the
end of the 2-wk sugar interventions. The 24-h TG profiles
during baseline and the end of the 2-wk intervention are
shown in Fig. 1, A–C. The 24-h TG AUC (Fig. 2A) was
significantly increased comparedwith baseline (LSmeans of
 different from zero) in subjects consuming fructose
(4.7  1.2 mmol/liter  24 h, P  0.0032) and HFCS
(1.81.4mmol/liter24h,P0.035),whereas it tended
to decrease during consumption of glucose (1.9  0.9
mmol/liter 24 h, P 0.14). The consumption of all three
sugars resulted in a late-evening TGpeak between 2200 and
2400 h that was not apparent when complex carbohydrate
wasconsumed(Fig.1,A–C).The late-eveningpeaks(Fig.2B)
were significantly increased compared with baseline during
consumption of fructose (0.59  0.11 mmol/liter, P 
0.0001) andHFCS (0.460.082mmol/liter,P0.0001)
butnotbyglucose (0.220.10mmol/liter,P0.077).All
three sugars tended to increase fasting TG, but this was sig-
nificant only in the group consuming glucose (Fig. 2C). Fast-
ing LDL-C concentrations (Fig. 3A) were increased during
consumption of fructose (0.29  0.082 mmol/liter, P 
0.0023) and HFCS (0.42 0.11 mmol/liter, P 0.0001)
but not glucose (0.012  0.071 mmol/liter, P  0.86).
TABLE 1. Subjects’ baseline anthropomorphic and
metabolic parameters
Parameter
Glucose
(n  16)
Fructose
(n  16)
HFCS
(n  16)
Age (yr) 27.0  7.2 28.0  6.8 27.8  7.6
Weight (kg) 76.8  14.1 76.8  10.6 74.3  14.9
BMI (kg/m2) 26.2  3.6 25.4  3.8 24.9  4.8
Waist circumference
(cm)
80.6  10.4 77.8  9.6 78.0  10.8
Body fat (%) 28.0  9.3 26.7  11.8 25.0  10.1
TG (mmol/liter) 1.2  0.5 1.2  0.4 1.3  0.6
Total cholesterol
(mmol/liter)
4.5  0.8 3.9  0.8 4.1  0.8
HDL-C (mmol/liter) 1.2  0.4 1.2  0.4 1.2  0.4
Insulin (pmol/liter) 97.9  30.4 102.8  86.4 89.1  31.6
P  0.05 for differences among groups at baseline for all parameters,
PROC MIXED ANOVA. Mean  SD.
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Similarly, fasting non-HDL-C (Fig. 3B), apoB (Fig. 3C), and
the apoB to apoAI ratio (Fig. 3D) were all significantly in-
creased in subjects consuming fructose (non-HDL-C:
0.29  0.066 mmol/liter, P  0.0081; apoB: 0.093 
0.022 g/liter, P  0.0005; apoB to apoAI ratio: 14.6 
3.8%, P 0.0006) andHFCS (non-HDL-C:0.55 0.14
mmol/liter, P  0.0001; apoB: 0.12  0.031 g/liter, P 
0.0001; apoB to apoAI ratio:19.5 4.4%, P 0.0001)
compared with baseline but not in subjects consuming glu-
cose (non-HDL-C: 0.055  0.080 mmol/liter, P  0.49;
apoB: 0.0097  0.019 g/liter, P  0.90; apoB to apoAI
ratio:1.9 2.5%, P 0.81).
Primary outcomes: comparing glucose, fructose,
and HFCS consumption
The effects of the three sugars were significantly different
(PROC MIXED two factor analysis with adjustment for
BMI, BW and outcomeB) for all primary outcomes except
fasting TG (see effects of sugar P values in Table 2). The
effects ofHFCS comparedwith fructose consumption on all
primaryoutcomeswerenot significantly different (P0.05,
Tukey’s). The increases in 24-h TGAUC (P 0.0068), late
eveningTGpeaks (P0.015), fastingapoB(P0.037),and
the apoB to apoA1 ratio (P 0.028) were larger after fruc-
tose consumptioncomparedwithglucose consumption.The
increases in 24-h TG AUC (P  0.034), fasting LDL (P 
0.0083), non-HDL-C (P0.0055), apoB (P0.0056), and
apoB to apoAI ratio (P  0.0034) were larger after HFCS
consumption than glucose consumption.
With regard to BMI, although the statistical results pre-
sented in Table 1 and Figs. 2 and 3 include adjustment for
BMI,Online Supplemental Fig. 1, A–F, presents the changes
of the primary outcomes with subjects grouped as normal
weight (BMI 25 kg/m2) or overweight/obese (BMI 25
kg/m2). The effect of BMI status was significant for the
changeof the24-hTGAUC(P0.016)and the late-evening
TG peaks (P 0.019) but not for the fasting TG (P 0.55,
datanotshown),LDL-C(P0.30),non-HDL-C(P0.93),
apoB (P 0.62), and apoB to apoAI ratio (P 0.51). Nor-
malweight andoverweight/obese subjects consumingHFCS
had comparable absolute (Supplemental Fig. 1) and percent
increases of late-eveningTG (BMI25kg/m2:4611%;
BMI 25 kg/m2: 31  6%), fasting LDL-C (BMI 25
kg/m2: 22  1%; BMI 25 kg/m2: 28  1%), non-
HDL-C (BMI 25 kg/m2: 36  19%, BMI 25 kg/m2:
17  7), apoB (BMI  25 kg/m2: 17  6%; BMI 25
kg/m2:20 8%), and the apoB to apoAI ratio (BMI25
kg/m2:22 7%; BMI25 kg/m2:20 9%).
Secondary outcomes: comparing glucose, fructose, and
HFCS with complex carbohydrate consumption
Table 3 presents the secondary outcomes during con-
sumption of complex carbohydrate at baseline and at the
end of the 2-wk sugar interventions. Fasting HDL con-
TABLE 2. Primary outcomes during consumption of complex carbohydrates at 0 wk and during consumption of
glucose-, fructose-, or HFCS-sweetened beverages at 2 wk
Primary outcomes
Glucose Fructose HFCS
Effects P value0 wk 2 wk 0 wk 2 wk 0 wk 2 wk
24-h TG AUC (mmol/liter per 24 h)a 5.6  1.1 3.6  1.3b 2.9  1.5 7.6  1.9*,c 3.8  1.4 5.5  1.7**,c Sugar 0.0058
Gender 0.13
BMI 0.0033
Late-evening TG (mmol/liter)d 1.3  0.2 1.5  0.2b 1.2  0.1 1.8  0.2***,c 1.3  0.2 1.8  0.2***,b,c Sugar 0.016
Gender 0.40
BMI 0.015
Fasting TG (mmol/liter)e 1.2  0.1 1.4  0.2* 1.2  0.1 1.3  0.1 1.3  0.2 1.4  0.1 Sugar 0.54
Gender 0.035
BMI 0.94
Fasting LDL-C (mmol/liter)a 2.6  0.2 2.6  0.2b 2.1  0.2 2.4  0.2*,b,c 2.3  0.2 2.7  0.2***,c Sugar 0.0098
Gender 0.057
BMI 0.40
Fasting non-HDL-C (mmol/liter)a 3.2  0.2 3.3  0.2b 2.7  0.2 3.0  0.2*,b,c 2.9  0.2 3.4  0.2***,c Sugar 0.0077
Gender 0.017
BMI 0.48
Fasting apoB (g/liter)a 0.82  0.06 0.83  0.06b 0.65  0.04 0.74  0.05****,c 0.73  0.05 0.85  0.06***,c Sugar 0.0051
Gender 0.027
BMI 0.47
apoB to apoAI ratioe 0.70  0.06 0.70  0.05b 0.54  0.04 0.63  0.05*,c 0.60  0.06 0.71  0.07***,c Sugar 0.0031
Gender 0.34
BMI 0.61
P  0.05 for differences among groups at baseline for all outcomes. Mean  SEM.
a PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI, BW (2 wk to 0 wk), and outcomeB on absolute  (2 wk vs. 0 wk).
b  (2 wk vs. 0 wk) significantly different from c  (2 wk vs. 0 wk), Tukey’s multiple comparison test.
d PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI on absolute  (2 wk vs. 0 wk).
e PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI and ‚BW (2 wk to 0 wk) on absolute ‚ (2 wk vs. 0 wk).
* P  0.01, ** P  0.05, *** P  0.0001, **** P  0.001, LS means of  different from zero.
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centrations were unaffected by consumption of the three
sugar-sweetened beverages. Similar to the responses in
the fasting state, subjects consuming fructose andHFCS
had increased postprandial concentrations of LDL-C,
non-HDL-C, and apoB compared with baseline, whereas
subjects consuming glucose did not. Fructose and HFCS
consumption increased postprandial concentrations of
RLP-C and RLP-TG compared with baseline, whereas
consumption of glucose did not. Consumption of all three
sugars increased fasting and postprandial sdLDL-C com-
pared with baseline.
Secondary outcomes: comparing glucose, fructose,
and HFCS consumption
The effects of the three sugars were significantly differ-
ent (PROC MIXED two factor analysis with adjustment
forBMI,BW,andoutcomeB) forpostprandialLDL,non-
HDL-C, apoB, RLP-C, and sdLDL-C (see effects of sugar
P values in Table 3). The effects of HFCS compared with
fructose consumption on all secondary outcomeswere not
significantly different (P  0.05, Tukey’s). The increases
in postprandial RLP-Cwere larger during consumption of
fructose compared with glucose (P  0.044), and HFCS
consumption caused larger increases in postprandial LDL
(P  0.0024), non-HDL-C (P  0.0007), apoB (P 
0.025), and sdLDL-C (P 0.014) (Tukey’s) than glucose
consumption.
For glucose, insulin, and HOMA-IR, the 24-h glucose
and insulin profiles during baseline (0 wk) and at the end
of the 2-wk intervention are presented in Online Supple-
mental Figs. 2, A–C, and 3, A–C, respectively. Compared
with baseline, the 24-h glucose and insulin 24-h AUC and
the postmeal insulin peaks were significantly increased in
subjects consuming glucose, significantly decreased in sub-
jects consuming fructose, and were unchanged in subjects
consuming HFCS (Online Supplemental Table 1). Postmeal
glucose peaks were increased in subjects consuming glucose
andHFCS.Fastingglucose concentrationswere significantly
decreased in subjects consuming glucose,whereas fasting in-
sulin concentrations and HOMA-IR did not change signif-
icantly in any group.
Gender
Although there were no significant sugar-gender inter-
actions foranyof theprimaryor secondaryoutcomes,men
TABLE 3. Secondary outcomes during consumption of complex carbohydrates at 0 wk and during consumption of
glucose-, fructose-, or HFCS-sweetened beverages at 2 wk
Secondary outcomes
Glucose Fructose HFCS
Effects P value0 wk 2 wk 0 wk 2 wk 0 wk 2 wk
Body weight (kg)a 76.8  3.5 77.2  3.7 76.8  2.6 76.7  2.6 74.3  3.7 74.7  3.7 Sugar 0.32
Gender 0.62
BMI 0.50
Fasting HDL (mmol/liter)b 1.2  0.1 1.2  0.1 1.2  0.1 1.1  0.1 1.2  0.1 1.2  0.1 Sugar 0.92
Gender 0.37
BMI 0.22
PP LDL (mmol/liter)b 2.5  0.2 2.6  0.2c 2.0  0.2 2.3  0.2*,c,d 2.1  0.2 2.7  0.2**,d Sugar 0.0033
Gender 0.010
BMI 0.54
PP non-HDL-C (mmol/liter)b 3.0  0.2 3.2  0.2c 2.5  0.2 3.0  0.2**,c,d 2.6  0.2 3.4  0.2**,d Sugar 0.0012
Gender 0.017
BMI 0.27
PP apoB (g/liter)b 0.78  0.05 0.83  0.05c 0.62  0.04 0.73  0.05***,c,b 0.68  0.05 0.84  0.06**,d Sugar 0.031
Gender 0.10
BMI 0.56
PP RLP-C (mmol/liter)a 0.17  0.02 0.19  0.02c 0.16  0.02 0.23  0.03**,b 0.15  0.02 0.21  0.02***,c,b Sugar 0.035
Gender 0.37
BMI 0.034
PP RLP-TG (mmol/liter)e 0.34  0.07 0.44  0.06 0.35  0.06 0.58  0.08*** 0.33  0.06 0.54  0.09*** Sugar 0.088
Gender 0.20
BMI 0.012
Fasting sdLDL-C (mmol/liter)f 0.65  0.08 0.77  0.10**** 0.47  0.04 0.59  0.06*** 0.61  0.08 0.78  0.09** Sugar 0.37
Gender 0.0019
BMI 0.11
PP sdLDL-C (mmol/liter)f 0.65  0.08 0.79  0.10*,c 0.48  0.04 0.64  0.07**,c,d 0.60  0.08 0.86  0.10**,d Sugar 0.019
Gender 0.0001
BMI 0.0125
P  0.05 for differences among groups at baseline for all outcomes. Mean  SEM. PP, Postprandial.
a PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI on absolute  (2 wk vs. 0 wk).
b PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI, BW (2 wk to 0 wk), and outcomeB on absolute  (2 wk vs. 0 wk).
c  (2 wk vs. 0 wk) significantly different from d  (2 wk vs. 0 wk), Tukey’s multiple comparison test.
e PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI and outcomeB on absolute  (2 wk vs. 0 wk).
f PROC MIXED two-factor (sugar, gender) analysis with adjustment for BMI and BW (2 wk to 0 wk) on absolute  (2 wk vs. 0 wk).
* P  0.01, ** P  0.0001, *** P  0.001, **** P  0.05, LS means of  different from zero.
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exhibited larger increases of fasting TG, non-HDL-C,
apoB, and sdLDL-C concentrations and postprandial
LDL, non-HDL-C, and sdLDL-C concentrations in re-
sponse to sugar consumption than women (see effects of
genderP values inTables 2 and3).However, postprandial
TG responses, as assessed by the 24-h TG AUC, late-eve-
ning TG peaks, postprandial apoB, and RLP-TG concen-
trations, were not different between genders. The subjects
consuming glucose exhibited the most divergent gender
responses, particularly in sdLDL-C. Fasting andpostpran-
dial sdLDL-C levels were increased compared with base-
line by 0.22  0.07 mmol/liter (P  0.0001) and
FIG. 1. Twenty-four-hour TG profiles during consumption of complex
carbohydrate and during consumption of sugar-sweetened beverages.
The change of 24-h TG concentrations over fasting concentrations during
consumption of energy-balanced baseline diet containing 55% E complex
carbohydrate at 0 wk and during consumption of energy-balanced
intervention diet containing 30% E complex carbohydrate and 25% E glucose
(A), fructose (B), or HFCS (C) at 2 wk (n 16/group). Data are mean SEM.
FIG. 2. Effects of sugar-sweetened beverage consumption on TG
concentrations. The change in 24-h TG AUC (A), late-night to late-
evening TG (B), and fasting TG concentrations (C) compared with
baseline after consuming 25% of energy requirements as glucose-,
fructose-, or HFCS-sweetened beverages for 2 wk is shown. S, P 
0.05; SS, P  0.01, effect of sugar; two-factor (sugar, gender) PROC
MIXED analysis on  with adjustment for BMI (B), BW (C), and
outcome at baseline (A). *, P  0.05, **, P  0.01, ****, P  0.0001,
LS means different from zero. A,  different from B; , Tukey’s (n 
16/group). Data are mean  SEM.
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0.24  0.05 mmol/liter (P  0.0001), respectively, in
men after glucose consumption but were unchanged in
women (fasting sdLDL-C:0.0040.02mmol/liter,P
0.61; postprandial sdLDL-C:0.0060.019mmol/liter,
P  0.69).
Discussion
The current study provides evidence that postprandial TG
and fasting and postprandial concentrations of LDL, non-
HDL-C, apoB, and the apoB to apoAI ratio, established
risk factors for coronary heart disease (25), are signifi-
cantly increased in response to 2 wk consumption of 25%
of E as fructose and HFCS, but not glucose, in younger,
normal-weight, and overweight subjects. In contrast and
as was observed in older subjects (15), fasting TG con-
centrations were increased in subjects consuming glucose
but not in those consuming fructose-containing sugars.
The differential effects of fructose and glucose consump-
tion on fasting and postprandial TG responses in subjects
from both studies suggest that fasting TG concentrations
are not a reliable indicator of the adverse changes in post-
prandial TG and other lipid/lipoprotein risk factors in-
ducedby fructose consumption.There is growingevidence
linking increases of postprandial TG concentrations with
proatherogenic conditions (26–28). It is important to note
that for both the current and previous study (15), the dif-
ferential effects of fructose and HFCS compared with
complex carbohydrate on the 24-h TG profile were most
marked in the late evening, approximately 4 and 6 h after
dinner. Studies investigating the relationship between this
late-evening peak and proatherogenic changes would be
of interest, as would investigations into the sources of the
TG that contributes to these peaks (de novo lipogenesis,
diet, or fatty acids derived from adipose lipolysis).
To our knowledge this is the first study to directly com-
pare the effects of sustained consumption of HFCS with
100% fructose and glucose-sweetened beverages. This
comparison is important because it would seem likely that
the effects of HFCS-sweetened beverages on circulating
lipids and lipoproteins would be less than those of pure
fructose-sweetened beverage because they contain 45%
FIG. 3. Effects of sugar-sweetened beverage consumption on risk factors for cardiovascular disease. The change in fasting LDL (A), non-
HDL-C (B), apoB concentrations (C), and apoB to apoA1 ratio (D) after consuming 25% of energy requirements as glucose-, fructose-, or
HFCS-sweetened beverages for 2 wk. ss, P  0.01, effect of sugar; two-factor (sugar, gender) PROC MIXED analysis on  with adjustment
for BMI, BW (D), and outcome at baseline (A–C). **, P  0.01, ***, P  0.001, ****, P  0.0001, LS means different from zero. A, 
different from B, , Tukey’s (n  16/group). Data are mean  SEM.
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less fructose. And indeed, the postprandial TG and RLP
responses exhibited the expected pattern based on the
fructose content of the sugars, with increases being great-
est in subjects who consumed 145  4 g fructose per day
from beverages, lowest in subjects who consumed 144 
5gglucoseper day and0g fructose per day frombeverages
and intermediate in subjects who consumedHFCS-sweet-
ened beverages providing 64  2 g glucose per day and
79 3 g fructose per day.However, the changes of fasting
and postprandial concentrations of LDL, non-HDL-C,
apoB, and the apoB to apoAI ratio in subjects consuming
HFCS were significantly larger compared with subjects
consumingglucose and tended tobehigher comparedwith
subjects consuming pure fructose. More studies are
needed to confirm this unexpected pattern and to deter-
mine whether it is a result of a synergistic effect of con-
suming fructose and glucose in combination. Additional
studies are also needed to determine whether the substan-
tial increases, seen after just 2 wk, are further aggravated
with longer-term consumption of HFCS-sweetened
beverages.
Compared with baseline, postmeal glucose and insulin
responses (indexed as 24hAUCandpostmeal peaks)were
mainly increased during glucose consumption, decreased
during fructose consumption, and unchanged during
HFCS consumption. This pattern is expected and further
supports our data indicating that the adverse effects asso-
ciated with chronic consumption of sugar-sweetened bev-
erages result from the specific effects of fructose (29),
rather than from increased circulating glucose and insulin
excursions (i.e. glycemic index) (30–32). Although con-
sumption of fructose increased fasting glucose and insulin
concentrations in 2wkanddecreased insulin sensitivity by
17% in 10 wk (15), in the current study, HOMA-IR was
unchanged after 2 wk consumption of fructose, HFCS, or
glucose. This may be related to the subjects in the current
study being younger and leaner (28  7 yr; 25.5  4.0
kg/m2) than the subjects in the previous study (54 8 yr;
29.1  2.9 kg/m2). In a study by Le et al. (33), inclusion
of fructosewithanenergy-balanceddiet for4wk inyoung,
normal-weight men (24.7 1.3 yr;	22 kg/m2) increased
fasting glucose levels, but other indices of insulin sensitiv-
ity were unaffected. However, it was recently reported
that consumption of fructose or glucose (150 g/d) for 4wk
lowered insulin sensitivity and increased HOMA-IR in
subjects of similar age and BMI (31  9 yr; 25.9  2.2
kg/m2) (34).
As would be expected based on the evidence that both
increasing age and postmenopausal status result in aug-
mented postprandial lipid responses in women (35), more
significant gender differences in lipid outcomes were ob-
served in these younger subjects in the current study than
in the older subjects previously studied (15). With the ex-
ception of postprandial TG, apoB, and RLP-C and RLP-
TG, younger men exhibited larger lipoprotein responses
after 2 wk of sugar consumption than younger women.
The comparable responses in postprandial TG and apoB
concentrations and the significantly different fasting TG
and apoB responses between the genders suggest that rates
of very low-density lipoprotein secretion may be similar
between men and women, whereas rates of very low-den-
sity lipoprotein clearance are different. This is supported
by kinetic studies, which demonstrate that women have
higher TG-rich lipoprotein and LDL-apoB fractional cat-
abolic rates than men, whereas production rates are com-
parable (36, 37).
The greater effect of glucose consumption on sdLDL-C
levels in youngermen comparedwith youngerwomen rep-
resents the most marked difference between the current
and our previous lipid results, which showed older men
andwomenwere comparably nonresponsive to consump-
tion of glucose (15). The increase of fasting sdLDL-C con-
centrations compared with baseline in younger men con-
suming glucose was unexpected because they did not
exhibit increases in fasting LDL and apoB concentrations.
The added sugar component of the typical U.S. diet
consists of nearly equal amounts of HFCS and sucrose
(38); therefore, it is a limitation of this study that we did
not also investigate the effects of sucrose consumption.
However, we expect that the effects of sucrose would be
comparable with those of HFCS because its composition
(50% glucose/50% fructose) is very similar to the com-
position of the HFCS used for this study (45% glucose/
55% fructose). This is supported by results from a cross-
over study in which subjects consumed standardized diets
containing 5, 18, or 33% of energy as sucrose, each for 6
wk. Compared with the 5% sucrose diet, LDL concentra-
tions increased by 17% on the 18% sucrose diet and by
22% on the 33% sucrose diet (39).
Self-reported intake data suggest that 13% of the U.S.
population consumes 25% or more of energy from added
sugar (40). Importantly, the current results provide evi-
dence that sugar consumption at this level increases risk
factors for cardiovascular disease within 2 wk in young
adults, thus providing direct experimental support for the
epidemiological evidence linking sugar consumption with
dyslipidemia (1–5) and cardiovascular disease (13). The
results contradict the conclusions from recent reviews that
sugar intakes ashighas25–50%of energyhavenoadverse
long-term effects with respect to components of the met-
abolic syndrome (16) and that fructose consumption up to
140 g/d does not result in a biologically relevant increase
of fasting or postprandial TG in healthy, normal-weight
(17) or overweight or obese (18) humans. Additionally
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they provide evidence that the maximal upper limit of
25% of total energy requirements from added sugar, sug-
gested by theDietaryGuidelines forAmericans 2010 (19),
may need to be reevaluated.
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